Hiperplasia prostática benigna. Diagnóstico, tratamiento y nuevas estrategias terapéuticas: revisión narrativa
Year: 2026
Type: article
Abstract: Benign prostatic hyperplasia (BPH) is one of the most common urological diseases in older men, with a significant impact on quality of life and a considerable burden on public health systems. This review aimed to analyze the clinical, epidemiological, and therapeutic aspects of BPH, including the most recent advances in pharmacological treatments and minimally invasive surgical procedures. A narrative review of the scientific literature published between 2019 and 2025 was conducted using databases such as PubMed and Scopus, employing MeSH terms related to BPH and its interventions. High-impact studies in English and Spanish, as well as relevant clinical guidelines, were included. The results show that BPH management can be approached in a stepwise manner, ranging from conservative interventions to pharmacological treatments (alpha-blockers, 5-alpha reductase inhibitors, antimuscarinics, and PDE-5 inhibitors) and surgical options. Phytotherapy has not demonstrated sufficient evidence due to the lack of well-defined mechanisms and clinical trials; therefore, its use should be interpreted with caution and considered as a complementary rather than an alternative therapeutic option. Minimally invasive therapies such as Rezūm and Prostatic Urethral Lift (PUL) stand out, offering efficacy comparable to transurethral resection of the prostate (TURP) with less impact on sexual function and shorter recovery time. The ideal treatment should be selected based on symptom severity, prostate volume, comorbidities, and patient preferences. In conclusion, BPH continues to represent a relevant clinical challenge that requires evidence-based, patient-centered therapeutic decisions tailored to available resources, especially in contexts where equitable access to the most effective and sustainable therapeutic options must be ensured
Author: Andrés Sebastián Aroca Mantilla
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7125512392
